Amy Bingaman, MD, MSCP, FACOG

Clinical background

Amy Bingaman, MD, MSCP, FACOG, is a board-certified gynecologist with a clinical focus on perimenopausal and menopausal care. She has practiced since 2006 and provides gynecologic care across central and western Iowa.

Dr. Bingaman earned her medical degree from the University of Iowa in 2002, holds a Master of Science in Clinical Psychology, and completed her obstetrics and gynecology internship and residency at Naval Medical Center Portsmouth. She served 8.5 years on active duty in the United States Navy. Her clinical work also includes adolescent gynecology, LGBTQ+ health, and gynecologic surgery, with an emphasis on patient education and shared decision-making.

At Veradene, Dr. Bingaman provides medical review across the full editorial program, including perimenopause, menopause, hormone therapy, weight and metabolic health, testosterone therapy for women, hair loss, skin health, and peptides. She reviews each article for medical accuracy, safety, appropriate clinical context, and fidelity to the cited evidence and relevant clinical guidance.

Credentials and training

• Board-certified in obstetrics and gynecology
• Menopause Society Certified Practitioner (MSCP)
• Fellow of the American College of Obstetricians and Gynecologists (FACOG)
• Doctor of Medicine, University of Iowa, 2002
• Master of Science in Clinical Psychology
• Obstetrics and gynecology residency, Naval Medical Center Portsmouth
• 8.5 years of active-duty service in the United States Navy
• In clinical practice since 2006
• Member of the Iowa Medical Society

Clinical practice and professional education

• Cass Health and Atlantic Medical Center: Provides full-spectrum gynecologic care in Atlantic, Iowa, including perimenopausal and menopausal care, hormone therapy, adolescent and LGBTQ+ care, and gynecologic surgery.
• Montgomery County Memorial Hospital: Provides visiting gynecology care in Red Oak, Iowa, with a focus that includes perimenopause, menopause, adolescent care, LGBTQ+ care, and robotic gynecologic surgery.
• Perimenopause professional education: Was announced as the clinician for a two-hour 2025 Family Planning Council of Iowa training on sexual and reproductive health care for perimenopausal and menopausal patients.

What Dr. Bingaman reviews

Dr. Bingaman reviews Veradene articles about perimenopause, menopause, hormone therapy, weight and metabolic health, testosterone therapy for women, hair loss, skin health, and peptides. Across this full editorial program, she evaluates clinical accuracy, safety, context, and whether the article's conclusions reflect its cited research and relevant clinical guidance.

• The article's main answer is clinically accurate for women in midlife.
• Benefits, risks, eligibility, monitoring, and treatment limits are described in proportion to the evidence.
• Red flags and reasons to seek urgent or in-person care are clear.
• The cited research and clinical guidance support the claims that matter to a health decision.

The article byline identifies the author and medical reviewer separately. Read more about corrections, sourcing, and review dates in Veradene’s editorial policy.

Clinical focus and medical review

Clinical focus

• Full-spectrum gynecologic care
• Perimenopausal, menopausal, and postmenopausal care
• Menopausal hormone therapy, including bioidentical hormone replacement therapy
• Adolescent gynecology
• LGBTQ+ gynecologic care
• Robotic gynecologic surgery
• Midlife women's health

Veradene medical review areas

Dr. Bingaman provides medical review across Veradene’s full editorial program. The review covers the following areas of women’s health and midlife care.

• Perimenopause symptoms, timing, bleeding changes, diagnosis, and treatment options
• Menopause and postmenopause symptoms, hormone therapy, bioidentical hormones, and nonhormonal care
• Sexual health in midlife, genitourinary symptoms of menopause, and testosterone therapy for women
• Weight and metabolic health after 40, including GLP-1 medicines, insulin resistance, and PCOS in midlife and after menopause
• Hair thinning, hair-loss treatments, and scalp health in midlife
• Skin changes after menopause, including acne, skin aging, and pigmentation
• Peptides and other emerging therapies, including evidence, safety, monitoring, and regulatory status